Manufacturing and Value Chains

This biotech company claims to have 3D printed a mini human heart 

A 3D printer prints what Israeli scientists from Tel Aviv University say is the world’s first 3D-printed, vascularised engineered heart, during a demonstration at a laboratory in the university, Tel Aviv, Israel April 15, 2019. REUTERS/Amir Cohen - RC13FA2CB9D0

It sports four major internal chambers and other structures, like valves, that are usually found inside the human heart. Image: REUTERS/Amir Cohen - RC13FA2CB9D0

Victor Tangermann
Writer and Photo Editor, Futurism
Share:
Our Impact
What's the World Economic Forum doing to accelerate action on Manufacturing and Value Chains?
The Big Picture
Explore and monitor how Biotechnology is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

Biotechnology

There’s a national shortage of donor organs in the United States — a terrifying predicament for the hundreds of thousands of patients on transplant waiting lists. But a new technology has the chance to one day make the donor organ obsolete.

Chicago-based biotech outfit Biolife4D claims to have 3D bioprinted a miniaturized human heart — chambers, ventricles, and all. Though it’s still years out, the long-term goal is to print full-scale human hearts that can be transplanted into human patients, like changing out a watch battery.

The company used a proprietary bioink — the company described it as “similar in properties to gelatin” — that was designed from the ground up to replicate actual human biomaterials. The heart was printed the same way a consumer-grade 3D printer prints small objects: layer by layer. To help with structural integrity during the printing process, Biolife4D printed an additional support scaffold encasing the heart.

Loading...

Once fully printed, the heart was transferred to a bioreactor that mimics the conditions of the human body, helping the cells fuse themselves into tissue.

It’s one of many recent breakthroughs in 3D bioprinting technology. An Israeli lab at Tel Aviv University made headlines in April with its similarly-miniaturized 3D-printed heart that uses the patient’s own cells. Israeli media claimed it was the “world’s first” 3D printed heart of its kind.

What sets its own mini-heart apart, according to Biolife4D, is its inner workings. It sports four major internal chambers and other structures, like valves, that are usually found inside the human heart.

Despite the advancements, the mini heart is far from ready for transplant. And rather than ensuring survival of a human patient, the mini heart could alternately become a viable tool for cardiotoxicity testing — the study of how drug treatments and medications could damage heart muscles.

In fact, that’s what it was designed to do in the first place. According to Ravi Birla, the Chief Science Officer at BIOLIFE4D, the heart represents the company’s “first potential opportunity to move the incredible technology to the market.”

The company is already planning to scale up production to eventually bioprint a full-size human heart. But that may be a lot trickier than it sounds as it would require multiple cell types to be delivered to different regions — a process that might necessitate the development of “additional inks” according to Birla.

Biolife4D still has plenty of work to do before it can successfully transplant its printed heart into human or animal patients. Because after all, as Birla puts it, “the bar which must be met to survive in an animal for its life is higher than the bar to bioengineer a mini heart to be used for cardiotoxicity testing.”

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Related topics:
Manufacturing and Value ChainsFourth Industrial Revolution
Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

1:47

Here's how the metaverse is transforming ship design

Aleksander Ciszek and Devin Culham

April 25, 2024

About Us

Events

Media

Partners & Members

  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2024 World Economic Forum